Credited from: INDIATIMES
Former U.S. CDC Director Susan Monarez testified before a Senate panel that Health Secretary Robert F. Kennedy Jr. pressured her to approve changes to the childhood vaccination schedule without required scientific evidence. Monarez detailed how she was directed to dismiss career scientists and support every recommendation from the Advisory Committee on Immunization Practices (ACIP), which had been overhauled with members more aligned with Kennedy's views, according to Reuters and Los Angeles Times.
Monarez, who served only 29 days in her role, insisted that her dismissal stemmed from her refusal to compromise scientific integrity in vaccine policy. During a controversial meeting on August 25, Kennedy informed her of plans to alter the vaccine schedule starting in September and demanded her support for these changes, which she found unprecedented given the lack of supporting data, as reported by BBC and India Times.
The testimony unveiled growing concerns among lawmakers including Senator Bill Cassidy, chair of the Senate Committee on Health, Education, Labor, and Pensions, who stressed the importance of evidence-based science in vaccine decisions. He noted the historical significance of the hepatitis B vaccine, which has drastically reduced infections in newborns, contrasting sharply with Kennedy's push for changes, according to The Hill and Vox.
Monarez’s account highlighted a tense climate within the CDC, where Kennedy had been accused of censoring scientific information and politicizing health decisions. Former Chief Medical Officer Debra Houry resigned following Monarez's firing, expressing that Kennedy's leadership undermined the organization's integrity and scientific foundation, as covered by Newsweek and Al Jazeera.
Monarez's warnings about the potential return of preventable diseases such as polio and whooping cough, coupled with rising skepticism about vaccine safety, pose significant public health concerns. As her testimony unfolds, it reflects the tension between political agendas and scientific data in shaping U.S. health policies amid debates in Congress, according to India Times and Reuters.